Literature DB >> 36087234

Radiation-Induced Cardiovascular Toxicities.

Shahed N Badiyan1, Lindsay L Puckett2, Gregory Vlacich1, Walter Schiffer3, Lauren N Pedersen1, Joshua D Mitchell3,4, Carmen Bergom5,6.   

Abstract

OPINION STATEMENT: Several seminal papers over the last decade have furthered our recognition of radiation-induced heart disease (RIHD) as an important potential toxicity following radiation therapy (RT) to the chest. Investigators continue to evaluate the subacute and long-term effects of RT. In addition, studies are determining whether certain cardiac substructures are more sensitive to radiation, working to identify risk factors for the development of RIHD, and testing screening and mitigation strategies for RIHD. Multiple groups and expert consensus guidelines have published whole-heart and cardiac substructure dose constraints based on available data and cancer type. The authors recommend readers to familiarize themselves with the guidelines for screening and mitigating RIHD in adults and children, which advocate for cardiovascular risk assessment and reduction before and following RT, as well as cardiovascular imaging at appropriate follow-up intervals for early recognition of subclinical cardiovascular disease. Referrals to cardiology or cardio-oncology can also be helpful in prevention, screening, and mitigation strategies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiac; Cardio-oncology; Heart; Radiation; Toxicity

Mesh:

Year:  2022        PMID: 36087234     DOI: 10.1007/s11864-022-01012-9

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  81 in total

1.  Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors.

Authors:  A Pirzkall; M Carol; F Lohr; A Höss; M Wannenmacher; J Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

2.  Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.

Authors:  Steven H Lin; Brian P Hobbs; Vivek Verma; Rebecca S Tidwell; Grace L Smith; Xiudong Lei; Erin M Corsini; Isabel Mok; Xiong Wei; Luyang Yao; Xin Wang; Ritsuko U Komaki; Joe Y Chang; Stephen G Chun; Melenda D Jeter; Stephen G Swisher; Jaffer A Ajani; Mariela Blum-Murphy; Ara A Vaporciyan; Reza J Mehran; Albert C Koong; Saumil J Gandhi; Wayne L Hofstetter; Theodore S Hong; Thomas F Delaney; Zhongxing Liao; Radhe Mohan
Journal:  J Clin Oncol       Date:  2020-03-11       Impact factor: 44.544

Review 3.  Proton radiation in the management of localized cancer.

Authors:  Harald Paganetti; Hanne Kooy
Journal:  Expert Rev Med Devices       Date:  2010-03       Impact factor: 3.166

4.  Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

Authors:  Stephen G Chun; Chen Hu; Hak Choy; Ritsuko U Komaki; Robert D Timmerman; Steven E Schild; Jeffrey A Bogart; Michael C Dobelbower; Walter Bosch; James M Galvin; Vivek S Kavadi; Samir Narayan; Puneeth Iyengar; Clifford G Robinson; Raymond B Wynn; Adam Raben; Mark E Augspurger; Robert M MacRae; Rebecca Paulus; Jeffrey D Bradley
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

5.  Exposure of the heart in lung cancer radiation therapy: A systematic review of heart doses published during 2013 to 2020.

Authors:  Maeve Kearney; Maeve Keys; Corinne Faivre-Finn; Zhe Wang; Marianne C Aznar; Frances Duane
Journal:  Radiother Oncol       Date:  2022-05-13       Impact factor: 6.280

6.  Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.

Authors:  M V Maraldo; N P Brodin; M C Aznar; I R Vogelius; P Munck af Rosenschöld; P M Petersen; L Specht
Journal:  Ann Oncol       Date:  2013-04-25       Impact factor: 32.976

Review 7.  A decade of comparative dose planning studies for early-stage Hodgkin lymphoma: what can we learn?

Authors:  Maja V Maraldo; Lena Specht
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-12-01       Impact factor: 7.038

8.  Implementation of three dimensional conformal radiation therapy: prospects, opportunities, and challenges.

Authors:  S Vijayakumar; G T Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-12-01       Impact factor: 7.038

Review 9.  Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC.

Authors:  Harald Paganetti; Clemens Grassberger; Gregory C Sharp
Journal:  Semin Radiat Oncol       Date:  2021-04       Impact factor: 5.421

10.  FDG PET/CT in the Staging of Lung Cancer.

Authors:  Mohsen Farsad
Journal:  Curr Radiopharm       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.